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Background: Septic cavernous sinus thrombosis (CST) is a rare and fatal disease. Clinical presentations in
the early stage are nonspecific, and the sensitivity of cranial axial computed tomography (CT) with thick
section is low. This study analyzed the clinical manifestation and neuroimaging findings in patients with
septic CST in a medical center in Taiwan.
Methods: This retrospective case series included nine patients with septic CST who had typical symptoms
and clinical course, evidence of infection, and imaging studies which demonstrated cavernous sinus lesion,
and who were treated between 1995 and 2003 at National Taiwan University Hospital.
Results: Seven (77.8 %) patients were more than 50 years old. Five (55.6%) had diabetes, and three (33.3%)
had hematologic diseases. All cases were associated with paranasal sinusitis. The most frequent initial symptom
was headache (66.7%), followed by ophthalmic complaints (diplopia or ophthalmoplegia, 55.6%; blurred
vision or blindness, 55.6%), and ptosis (44.4%). Initial cranial images failed to identify CTS in all patients.
Subsequent magnetic resonance imaging (MRI) or coronal contrast-enhanced CT (CECT) with thin section
confirmed the diagnosis. Fungi were the most common pathogens (55.6%). The inhospital case-fatality rate
was high (44.4%).
Conclusion: Due to the high case-fatality rate and low yield rate of blood cultures, fungal CST should be
suspected in an immunocompromised patient with ophthalmic complaints that progress from one eye to
the other. Coronal thin-section CECT may be a useful alternative to MRI as a diagnostic modality for this
condition. [J Formos Med Assoc 2006;105(3):203–209]
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Septic cavernous sinus thrombosis (CST) was
first described by Duncan in 1821.1 It is a rare in-
fective disease, and had up to 80% mortality and
75% residual morbidity in the pre-antibiotic
era.2 Mortality (13.6%) and morbidity (23%) have
remained high in the modern era due to delay in
diagnosis.3 Imaging studies such as contrast-
enhanced computed tomography (CECT), mag-
netic resonance imaging (MRI) and venography
have had a significant impact on the diagnosis of
CST in recent decades.
Septic CST is an uncommon and fatal disease.
*Correspondence to: Dr. Yee-Chun Chen, Division of Infectious Diseases, Department of Internal Medicine, National
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Early diagnosis and aggressive treatment are
very important. With the increasing prevalence
of immunocompromised patients, the clinical
features and pathogens of septic CST should be
re-evaluated. The present study retrospectively an-
alyzed the clinical features of septic CST in patients
treated over a 9-year period.
Methods
This study was a retrospective case series. National
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The diagnosis of septic CST was confirmed within
1–16 days of the first ophthalmic complaint
(median, 4.5 days). Case 6 was referred from an-
other hospital; he died quickly and the duration
between ophthalmic complaint and diagnosis of
septic CST was unknown.
Imaging studies revealed acute or chronic
paranasal sinusitis in all nine patients with eth-
moid (66.7%) and sphenoid (44.4%) sinuses
most frequently involved. The causative patho-
gens of septic CST were identified from blood cul-
tures in three patients with Gram-positive bactere-
mia (33.3%). Fungi were identified from sinus
biopsy in five (55.6%) cases, which included zy-
gomycete (3 patients), Aspergillus (1) and uniden-
tified fungus (1). One patient died rapidly but
no infectious etiology was identified. Case 8 un-
derwent lumbar puncture and culture of cerebro-
spinal fluid was negative.
When severe headache or ophthalmic symp-
toms appeared, imaging studies were performed,
which included cranial axial CECT in five (55.6%)
patients, MRI in two (22.2%), and sinusal/orbital
coronal CT without contrast in two (22.2%). How-
ever, none of these images focused on cavernous
sinuses because CST was not initially suspected.
Progression of symptoms and signs led to the
performance of secondary imaging study, which
confirmed the diagnosis of CST in seven patients,
based on MRI in five patients, axial CECT in one,
and coronal CECT with thin section (3-mm-thick
sections) in one. Filling defects in the cavernous
sinus and abnormal signals of cavernous sinuses
on CT or MRI (identified in 8 of 9 patients) were
the most common imaging findings (Table 2;
Figures 1 and 2).
The inhospital case-fatality rate of the nine
patients with CST was 44.4%. Three patients died
within 5–16 days after the diagnosis of CST, and
another patient died suddenly of unknown cause
after recovery from the infection. Of the five pa-
tients who survived, two (40%) had sequelae
of blindness or blurred vision. Case 4 developed
ophthalmic symptoms after initial response to an-
tibiotic therapy and operation for left frontal
abscess, but recurrent septic CST with symptoms
Taiwan University Hospital (NTUH), a major
teaching hospital in Taiwan with 2200 beds,
provides both primary and tertiary medical care.
The medical records and images of 149 patients
hospitalized at NTUH from 1995 through 2003
with the discharge diagnosis of thrombophlebi-
tis of intracranial venous sinuses were reviewed.
Those with clinical diagnosis alone, no imaging
study or spontaneous resolution of symptoms
were excluded. Only cases with typical symptoms
(such as fever, headache, facial pain, blurred vi-
sion or blindness, diplopia, and ophthalmoplegia)
and clinical course, evidence of infection, and im-
aging studies that demonstrated cavernous sinus
lesion were included in this study. Ophthalmo-
logists or otolaryngologists were consulted to
exclude fulminant sinusitis or ophthalmitis. Age,
gender, underlying diseases, initial presentation,
laboratory and microbiologic data, treatment
courses and complications were recorded and
analyzed.
Results
Septic CST was diagnosed in a total of nine pa-
tients (2 women; 7 men) during the study period.
The median age was 62 years (range, 16–79 years).
Seven (77.8%) patients were older than 50 years,
and the remaining two younger patients had he-
matologic malignancy (cases 2 and 3; Table 1). Five
patients had diabetes and three had hematologic
diseases (Table 1). None of the patients had a re-
cent history of steroid use. Pain was the most com-
mon initial presentation (Table 2), including either
headache or facial pain in five (55.6%) patients
and orbital pain in one (11.1%). The interval be-
tween onset of pain and diagnosis of septic CST
ranged from 3 to 60 days (median, 17 days). All
patients had ophthalmic complaints which be-
gan in the left eye (6 patients, 66.7%), right eye (2
patients, 22.2%), or both eyes (1 patient, 11.1%).
Progression from one eye to the other occurred
within 10 days in three (33.3%) patients. The most
frequent ophthalmic complaints were blurred
vision/blindness or diplopia/ophthalmoplegia.
205J Formos Med Assoc | 2006 • Vol 105 • No 3
Septic cavernous sinus thrombosis
in the other eye developed 1.5 months after the
previous episode.
Discussion
This study demonstrated several unique features
of host factors as well as the etiologies of septic
CST compared to previous reports. Patients in this
study were older and more likely to be immuno-
compromised than in early reports.4,5 Diabetes is
a risk factor for many infectious diseases,6 and
was the most common underlying disease in this
series. In contrast, diabetes was not emphasized
as a risk factor for septic CST in other studies.4,5,7
Fever was a very common presentation of septic
CST (> 90%) in a recent review,7 but only 33.3%
of our patients had fever in the early stage. These
Pathogens/
Isolated from
Zygomycete/
Sinus biopsy
Staphylococcus
simulans/blood
–
Fungus,
unidentified/
sinus biopsy
Peptostreptococcus
micros/blood
Zygomycete/
sinus biopsy
Zygomycete/
sinus biopsy
Streptococcus
constellatus/
blood
Aspergillus/
sinus biopsy
Initial presentations
(delay between onset
and diagnosis, d)
Left facial pain (10),
blurred vision (4),
ophthalmoplegia (2)
Left eye blindness (1)
Headache (3); left eye
pain, eyelid swelling,
ptosis and ophthalmo-
plegia (3)
Left proptosis and
ophthalmoplegia (16)
Headache, bilateral ptosis
and right proptosis (15)
Left blindness and right
facial palsy (unknown)
Right orbital pain (5);
limited eye movement,
blurred vision, ptosis and
ophthalmoplegia (3)
Headache (10); right
ptosis, chemosis and
ophthalmoplegia (5)
Headache (60); acute loss
of left eye vision (2)
Cause of
death
Sepsis
–
Sepsis and
persistent
febrile
neutropenia
–
–
Unknown
Sepsis
–
–
Outcome,
complications/
Interval between
diagnosis and
death, d
Died (status
post surgery and
amphotericin B)/14
Survived, left
blindness
Died/5
Survived (status
post surgery and
amphotericin B)
Survived
Died/Unknown
Died (status post
amphotericin B)/16
Survived, blurred
vision
Survived, blurred
vision (surgery,
amphotericin B,
oral voriconazole)
Underlying
diseases/
conditions
Diabetes mellitus
Chronic myeloid
leukemia, allogenic
stem cell transplanta-
tion, graft-versus-host
disease
Acute myelogenous
leukemia, febrile
neutropenia
Diabetes mellitus
Asthma
Diabetes mellitus
Chronic
myeloproliferative
disease
Diabetes mellitus,
atrial fibrillation
Diabetes mellitus,
hypertension
Primary
foci of
infection
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Paranasal
sinusitis
Table 1. Clinical characteristics of nine patients with septic cavernous sinus thrombosis
Age
Case
(yr)
Gender
1 62 M
2 45 M
3 16 F
4 71 M
5 57 M
6 59 M
7 76 M
8 79 M
9 62 F
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findings may be due to the greater number of im-
munocompromised patients and the older age in
this series.
In this study, fungi, rather than Gram-positive
bacteria, were the main pathogens. In previous
studies, however, the most frequently isolated
pathogen was Staphylococcus aureus from facial in-
fections and paranasal sinusitis.3,8 Other bacteria
(such as streptococci, Gram-negative bacilli or
anaerobic bacteria), fungi (such as zygomycetes or
Aspergillus) or mixed infection were less frequently
reported in septic CST.3,5,9–11 The predominance of
fungal infection in this study may have been due
to the higher percentage of immunocompromised
patients. Pathogens were isolated from blood in
70% of patients in a previous study12 but in only
33.3% of patients in this series. The predominance
of molds, which are seldom isolated from blood,13
may explain this difference. The high inhospital
case-fatality rate (44.4%) in this study illustrates
the great importance of performing invasive diag-
nostic procedures early in immunocompromised
patients in order to guide their management based
on the findings. The higher rates of immunocom-
promise and zygomycosis seemed to contribute to
the higher case-fatality rate in this series. All three
patients with zygomycosis and one patient with
acute myeloid leukemia with febrile neutropenia
died.
Headache, including in the retro-orbital area,
and ophthalmic symptoms (periorbital edema,
chemosis, proptosis, ptosis and diplopia) are com-
mon initial complaints in patients with septic CST.
Thus, early septic CST is not easily distinguishable
from intrabulbal diseases, intraorbital lesions
such as orbital cellulitis, or vasodysformation in
Table 2. Symptoms, signs and imaging findings in nine patients with septic cavernous sinus
thrombosis
n (%)
Symptoms/Signs
Headache or facial pain 5 (55.6)
Diplopia or ophthalmoplegia 5 (55.6)
Blurred vision or blindness 5 (55.6)
Ptosis 4 (44.4)
Fever 3 (33.3)
Periorbital swelling or exophthalmos (proptosis) 2 (22.2)
Facial palsy or numbness 2 (22.2)
Photophobia 1 (11.1)
Orbital pain 1 (11.1)
Initial ophthalmic complaints: right/left/both 2 (22.2)/6 (66.7)/1 (11.1)
Progressed from one eye to the other 3 (33.3)
Imaging findings
Orbital cellulitis or exophthalmos 5 (55.6)
Engorged ophthalmic veins 3 (33.3)
Sinusitis or sinus lesions
Ethmoid 6 (66.7)
Sphenoid 4 (44.4)
Maxillary 3 (33.3)
Frontal 2 (22.2)
Filling defect in cavernous sinus 4 (44.4)
Contrast-enhanced and high-signal lesions on MRI 4 (44.4)
Increased density in cavernous sinus on CT 1 (11.1)
Abnormal finding in cavernous sinuses: right/left/both 2 (22.2)/3 (33.3)/3 (33.3)
CT = computed tomography; MRI = magnetic resonance imaging.
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the cavernous sinus such as an aneurysm or arteri-
ovenous fistula. Septic CST should, however, be
highly suspected in the presence of sepsis, cranial
nerve palsies and bilateral eye problems.4,9,14,15 Rap-
id progression of symptoms to the opposite eye
is an important distinguishing characteristic.8 In
this study, all patients had ophthalmic complaints.
Initial bilateral involvement occurred in one pa-
tient and progression from one eye to the other
occurred within 10 days in three. None of our pa-
tients had hypopituitarism, a rare complication of
septic CST.14
Since septic CST is a rare condition with non-
specific initial presentation, it is often missed,
underestimated, or diagnosed late. In this study,
correct diagnosis was not made until a second
imaging study was performed in seven of nine
patients. Orbital and retro-orbital pain were the
most common initial presentations. However,
these symptoms are not pathognomonic for sep-
tic CST. This may explain why the diagnosis of
CST was delayed from 3 to 60 days after onset of
headache in this study.
The results of this study demonstrated the
limitations of traditional CT with sections of 5–8
mm, which was not diagnostic for septic CST in
five patients. Two cases received CT that only
focused on the orbital cavity or sinuses, so cavern-
ous sinus was not seen on the images. Only one
case was diagnosed by traditional CT with 5–8-mm
sections, and another did not receive CT at all.
Traditional CT is often used as a rapid study for
intracranial lesions, but failed to detect lesions in
the cavernous sinuses in many cases.8,16 Thin-
section CECT (sections < 3 mm) is superior to tra-
ditional CT in evaluating the cavernous sinuses.8,16
The axial scan shows indirect signs such as straight-
ness of the lateral boundary of the cavernous si-
nuses, widening of the cavernous sinuses and en-
gorged ophthalmic veins (Figure 1A).16–19 Coronal
scan is more sensitive for the detection of direct
signs such as irregular filling defects, volume ex-
pansion or bulging of the lateral boundary of
the involved cavernous sinuses. It is also easier to
compare both cavernous sinuses and to evaluate
intracavernous neural or vascular structures (Figure
1B).19,20 Septic CST was diagnosed by MRI in
most of our patients. MRI is more sensitive than
CT in detecting septic CST because it can reveal
vasography and more multiplanar sections.17–19
Direct signs of CST on MRI include changes in
signal intensity and in the size and contour of the
cavernous sinuses; indirect signs include dilata-
tion of the tributary veins, exophthalmos, and in-
creased dural enhancement along the lateral bor-
der of the cavernous sinuses (Figure 2).18 CECT with
three-dimensional reconstruction can also reveal
  A
Figure 1. Case 8: (A) contrast-enhanced computed tomography (CT) with thin
section (3-mm thick section) and three-dimensional reconstruction in the axial view
reveals indirect signs of cavernous sinus thrombosis, including bilateral enlarged
superior ophthalmic veins (arrows) and soft tissue in the right retrobulbar region,
but does not show direct signs of abnormal cavernous sinuses; (B) coronal contrast-
enhanced CT with thin section (3-mm thick section) reveals filling defects and
bulges at bilateral cavernous sinuses (arrows).
  B
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vasography21 and more multiplanar sections, as in
case 8 of this series (Figure 1A), and may thus be a
useful alternative to MRI.
This study confirmed previous findings that
sinusitis is the most frequent focus and that sphe-
noid and/or ethmoid sinuses are most frequently
involved.7,22 Dental infections, especially from
maxillary teeth, and other infective foci, such as
meningitis, otic or orbital infection, or tonsillitis,
have been reported,7,23,24 but there were no such
cases in this series. With antibiotic treatment and
surgical removal of the primary foci, septic CST
secondary to these sites has become rarer.7,8,23,24
This study had several limitations. First, because
only cases with a diagnosis of CST were included,
and only image-confirmed cases were analyzed,
the clinical importance of septic CST may have
been underestimated in this retrospective study.
Second, the small case numbers in this study can-
not provide conclusive results concerning this rare
disease. Third, as neurologists were consulted in
less than half of the patients, the neurologic find-
ings in Table 1 might have been underestimated.
It was also difficult to confirm the diagnostic ben-
efit of CT and MRI because these imaging modali-
ties were not used simultaneously.
Conclusion
This study showed that fungi were the main path-
ogens of septic CST, typically occurring in immu-
nocompromised patients, and were associated with
a high case-fatality rate and a low yield rate from
blood cultures. Thus, fungal CST should be con-
sidered in the differential diagnoses in immuno-
compromised patients presenting with headache
and painful ophthalmoplegia. Progression of oph-
thalmic symptoms from one eye to the opposite
eye is an important clue to the presence of septic
CST. Coronal thin-section CECT (sections < 3 mm)
may be a useful alternative when MRI is not
available. Invasive diagnostic procedures, such
as endoscopic sinus surgery or biopsy, may be
necessary to allow early etiologic diagnosis and
guide antimicrobial therapy, particularly in immu-
nocompromised patients who have paranasal
sinusitis.
Figure 2. Case 7: (A) coronal T1-weighted magnetic resonance imaging (MRI) (TR/
TE: 980/14) with Gd-DTPA contrast enhancement demonstrates diminished
caliber and flow-void of the distal portion of the right internal carotid artery at the
cavernous sinus segment (arrow). The right cavernous sinus discloses mild enlarge-
ment with abnormal enhancement. (B) Axial T1-weighted MRI (TR/TE: 980/14)
with Gd-DTPA contrast enhancement shows abnormal signal intensity and
enlargement at the right cavernous sinus, diminished caliber and flow-void of
the distal portion of the right internal carotid artery at the cavernous sinus
segment (arrowhead) and thickening mucosa and fluid collection in the
right ethmoid sinus.
  A
  B
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